| Fratricide-resistant CD1a-specific CAR T cells for the treatment of cortical T-cell acute lymphoblastic leukemia D Sánchez-Martínez, ML Baroni, F Gutierrez-Agüera, H Roca-Ho, ... Blood, The Journal of the American Society of Hematology 133 (21), 2291-2304, 2019 | 97 | 2019 |
| 41BB-based and CD28-based CD123-redirected T-cells ablate human normal hematopoiesis in vivo ML Baroni, DS Martinez, FG Aguera, HR Ho, M Castella, SR Zanetti, ... Journal for immunotherapy of cancer 8 (1), 2020 | 42 | 2020 |
| CD133-directed CAR T-cells for MLL leukemia: on-target, off-tumor myeloablative toxicity C Bueno, T Velasco-Hernandez, F Gutiérrez-Agüera, SR Zanetti, ... Leukemia 33 (8), 2090-2125, 2019 | 38 | 2019 |
| A novel and efficient tandem CD19-and CD22-directed CAR for B cell ALL SR Zanetti, T Velasco-Hernandez, F Gutierrez-Agüera, VM Díaz, ... Molecular Therapy 30 (2), 550-563, 2022 | 27 | 2022 |
| Efficient elimination of primary B-ALL cells in vitro and in vivo using a novel 4-1BB-based CAR targeting a membrane-distal CD22 epitope T Velasco-Hernandez, SR Zanetti, H Roca-Ho, F Gutierrez-Aguera, ... Journal for immunotherapy of cancer 8 (2), 2020 | 10 | 2020 |
| Bone marrow clonogenic myeloid progenitors from NPM1-Mutated AML patients do not harbor the NPM1 mutation: implication for the Cell-Of-Origin of NPM1+ AML R Diaz de la Guardia, L González-Silva, B López-Millán, ... Genes 11 (1), 73, 2020 | 4 | 2020 |
| Innovative car t-cell based immunotherapy for the treatment of relapsed refractory acute leukemias ML Baroni Universitat de Barcelona, 2020 | | 2020 |
| PRECLINICAL OPTIMIZATION OF CHIMERIC ANTIGEN RECEPTOR CD123-EXPESSING T-CELLS FOR ACUTE MYELOID LEUKEMIA AND INCLUSION OF AN INDUCIBLE CASPASE 9 SUICIDE GENE TO INCREASE SAFETY ML Baroni HUMAN GENE THERAPY 29 (11), A18-A19, 2018 | | 2018 |
| The use of the model organism Drosophila melanogaster to investigate the role in metabolism and behavior of obesity-linked ML Baroni | | |
